Kyoto University's VC fund to invest $140m in AI and biotech

Miyako Capital to nurture Japan's nascent deep tech sector

20230803N StemRIM biotech

Miyako Capital has invested in over 50 companies, including regenerative medicine startup StemRIM. (Photo courtesy of StemRIM)

KENJIRO SUZUKI, Nikkei staff writer

TOKYO -- Kyoto University-affiliated venture capital firm Miyako Capital has established a fund expected to raise roughly 20 billion yen ($141 million) to back startups involved in deep-tech biology and artificial intelligence.

The fund will be one of the biggest vehicles of its kind in Japan, injecting between 500 million yen and 1 billion yen into each startup.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.